403 related articles for article (PubMed ID: 21764140)
1. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
2. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
Wimer CL; Damiani A; Osterrieder N; Wagner B
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
[TBL] [Abstract][Full Text] [Related]
4. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
[TBL] [Abstract][Full Text] [Related]
5. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
Platt R; Sponseller BA; Chiang YW; Roth JA
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
[TBL] [Abstract][Full Text] [Related]
7. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
8. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ
Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810
[TBL] [Abstract][Full Text] [Related]
9. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH
Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852
[TBL] [Abstract][Full Text] [Related]
10. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
[TBL] [Abstract][Full Text] [Related]
11. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
12. Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: viral loads in fetal and placental tissues and foals.
Gardiner DW; Lunn DP; Goehring LS; Chiang YW; Cook C; Osterrieder N; McCue P; Del Piero F; Hussey SB; Hussey GS
Vaccine; 2012 Oct; 30(46):6564-72. PubMed ID: 22944628
[TBL] [Abstract][Full Text] [Related]
13. Absence of relationship between type-I interferon suppression and neuropathogenicity of EHV-1.
Oladunni FS; Sarkar S; Reedy S; Balasuriya UBR; Horohov DW; Chambers TM
Vet Immunol Immunopathol; 2018 Mar; 197():24-30. PubMed ID: 29475503
[TBL] [Abstract][Full Text] [Related]
14. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
Allen GP; Breathnach CC
Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
[TBL] [Abstract][Full Text] [Related]
15. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
Paillot R; Daly JM; Luce R; Montesso F; Davis-Poynter N; Hannant D; Kydd JH
Dev Comp Immunol; 2007; 31(2):202-14. PubMed ID: 16824599
[TBL] [Abstract][Full Text] [Related]
16. Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses.
Allen GP
Am J Vet Res; 2006 Aug; 67(8):1401-5. PubMed ID: 16881853
[TBL] [Abstract][Full Text] [Related]
17. Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.
Sarkar S; Balasuriya UB; Horohov DW; Chambers TM
Vet Immunol Immunopathol; 2015 Oct; 167(3-4):122-9. PubMed ID: 26275803
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
19. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
